OptimizeRx Corp (OPRX) Financial Statements
Industry: Business Services (Other) (Services)
In fiscal 2025, OptimizeRx reported revenue of $109.4M, up 18.8% from $92.1M the year before. Net income was $5.1M (a 4.7% net margin), or $0.27 per diluted share. Gross margin was 67.3% and operating margin was 10.7%. Operating activities generated $18.7M of cash, leaving $18.7M of free cash flow. At fiscal year end, OptimizeRx held $176.9M in total assets against $48.6M in total liabilities, including $23.4M of cash and equivalents.
Open the full interactive OptimizeRx financials → Quarterly statements, key ratios, valuation history and price charts.
OptimizeRx Key Stats
| Share Price | $8.43 |
|---|---|
| Market Cap | $158.4M |
| P/E Ratio | 31.2 |
| Revenue YoY Growth | +18.8% |
| 52-Week Range | $4.54 – $21.68 |
| Shares Outstanding | 18.8 million (basic, 2026 Q2) |
OptimizeRx Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $43.3M | $61.3M | $62.5M | $71.5M | $92.1M | $109.4M |
| Gross Profit | $24.1M | $35.6M | $39.0M | $42.9M | $59.4M | $73.6M |
| Operating Income | -$2.1M | $361,100 | -$12.3M | -$26.4M | -$13.7M | $11.7M |
| Pre-Tax Income | -$2.2M | $378,079 | -$11.4M | -$25.2M | -$19.4M | $7.0M |
| Income Tax | — | — | — | -$7.6M | $725,000 | $1.8M |
| Net Income | -$2.2M | $378,079 | -$11.4M | -$17.6M | -$20.1M | $5.1M |
| Diluted EPS | -$0.15 | $0.02 | -$0.64 | -$1.03 | -$1.10 | $0.27 |
OptimizeRx Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $26.1M | $32.2M | $19.8M | $20.5M |
| Net Income | $779,000 | $5.0M | -$495,000 | -$703,000 |
| Diluted EPS | $0.04 | $0.26 | -$0.03 | -$0.04 |
OptimizeRx Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.5M | $84.7M | $18.2M | $13.9M | $13.4M | $23.4M |
| Current Assets | $32.9M | $115.1M | $98.6M | $54.3M | $54.0M | $64.7M |
| Total Assets | $60.3M | $141.0M | $134.7M | $183.4M | $171.2M | $176.9M |
| Current Liabilities | $10.0M | $9.4M | $8.4M | $17.9M | $18.7M | $21.3M |
| Total Long-Term Debt | — | — | — | $36.2M | $32.8M | $25.7M |
| Total Liabilities | $10.4M | $9.6M | $8.5M | $56.8M | $54.2M | $48.6M |
| Shareholders' Equity | $50.0M | $131.4M | $126.1M | $126.6M | $117.0M | $128.3M |
OptimizeRx Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$6.3M | $726,039 | $10.7M | -$7.2M | $4.9M | $18.7M |
| Cash From Investing | -$124,725 | -$485,999 | -$58.2M | -$25.3M | -$450,000 | $68,000 |
| Cash From Financing | -$1.9M | $73.9M | -$19.0M | $28.2M | -$4.9M | -$8.8M |
| Free Cash Flow | -$6.4M | $625,717 | $10.6M | -$7.3M | $4.8M | $18.7M |
Figures from OptimizeRx's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full OptimizeRx financials page for every line item.
OptimizeRx Company Profile
| Ticker | OPRX |
|---|---|
| Exchange | Nasdaq |
| Industry | Business Services (Other) (Services) |
| Headquarters | Waltham, Massachusetts |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001448431 |
Frequently Asked Questions
What was OptimizeRx's revenue in fiscal 2025?
OptimizeRx (OPRX) reported revenue of $109.4M for fiscal 2025.
What is OptimizeRx's annual revenue history?
OptimizeRx's annual revenue by fiscal year: 2020: $43.3M; 2021: $61.3M; 2022: $62.5M; 2023: $71.5M; 2024: $92.1M; 2025: $109.4M.
What was OptimizeRx's net income in fiscal 2025?
OptimizeRx reported net income of $5.1M for fiscal 2025.
What was OptimizeRx's earnings per share (EPS) in fiscal 2025?
OptimizeRx's diluted EPS was $0.27 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did OptimizeRx generate in fiscal 2025?
OptimizeRx generated $18.7M of free cash flow in fiscal 2025.
What was OptimizeRx's revenue last quarter?
In its most recent reported quarter (2026 Q2), OptimizeRx reported revenue of $20.5M.
How much debt does OptimizeRx have?
OptimizeRx reported $25.7M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of OptimizeRx are outstanding?
OptimizeRx reported a weighted average of 18.8 million basic shares outstanding in 2026 Q2.
What is OptimizeRx's market cap?
Based on its latest closing price, OptimizeRx (OPRX) has a market capitalization of about $158.4M.
When does OptimizeRx's fiscal year end?
OptimizeRx's fiscal year end, as registered with the SEC, is December 31.
Where is OptimizeRx headquartered?
OptimizeRx lists its business address in Waltham, Massachusetts in its SEC filings.